Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,408 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07314346RecruitingPhase 1
Study of a new hepatitis C drug with addiction medications
This study checks how a new hepatitis C medicine (bemnifosbuvir/ruzasvir) interacts with medications used for opioid addiction, such as buprenorphine/naloxone or methadone. It helps doctors understand if the new medicine is safe and effective for people taking these addiction treatments.
Hollywood, FloridaAges 18–65 - NCT07315360RecruitingPhase 1
How a new medicine works in people with reduced kidney function
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
Lake Forest, CaliforniaAges 18–80 - NCT07310264RecruitingPhase 1
Safety study of a new drug for Parkinson's disease
This trial tests a new drug called VT-5006 to see if it is safe for people with Parkinson's disease. It focuses on those who have stomach or bowel issues, like constipation.
LeidenAges 18–80 - NCT06660056RecruitingPhase 1
GC001 injection for returning or growing high-grade brain tumors
This trial tests a new drug, GC001, injected directly into the tumor in people with high-grade gliomas (WHO grade 3 or 4) that have come back or are growing. It may be an option if standard treatments have stopped working.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07313410Recruiting
Near-infrared light study for better understanding of PAD
This study uses near-infrared light to learn more about peripheral artery disease (PAD) in adults. It aims to help doctors better understand how PAD affects the body.
Arlington, TexasAges 18 years+ - NCT07312045Recruiting
Gum health and healing after non-surgical treatment
This study looks at how certain blood and saliva measurements relate to gum disease and healing after a deep cleaning. It may help find better ways to track gum health.
Merkez, ErzincanAges 18–65 - NCT07306793Recruiting
Mouth care and meal timing for preterm infants ready to eat
This study tests whether a gentle mouth care routine combined with a special feeding schedule helps preterm babies start eating by mouth more quickly and gain weight. It is designed for stable preterm infants born at 29-33 weeks.
AydinAges 7 months–8 months - NCT07314892Recruiting
Psychiatric health and symptom severity in GvHD patients
This study looks at how graft-versus-host disease (a complication after a bone marrow transplant) affects mental health and symptom severity. It aims to understand the connection so that doctors can better support patients.
Gdansk, Pomeranian VoivodeshipAges 18–75 - NCT07312916Recruiting
Hand massage for itching in kidney dialysis patients
This study tests whether hand massage can help reduce the chronic itching that many people on dialysis experience. It compares two groups to see if massage provides relief and improves quality of life.
Lausanne, Canton of VaudAges 18 years+ - NCT07310147Recruiting
Online ACT therapy for young-onset Parkinson’s
This trial tests an online program based on Acceptance and Commitment Therapy (ACT) to help people with young-onset Parkinson’s disease cope better with life challenges. It aims to improve emotional well-being and quality of mind.
CoimbraAges 21–65 - NCT07312305Recruiting
Small airways test in idiopathic pulmonary fibrosis
This study measures how well the small airways in your lungs work if you have idiopathic pulmonary fibrosis (IPF). It aims to find better ways to assess the disease and could lead to improved care.
Milan, LombardyAges 18 years+ - NCT05465031RecruitingPhase 4
Testing heart-protection medicine during breast cancer treatment
This trial tests sacubitril/valsartan to help prevent heart weakness (cardiotoxicity) caused by breast cancer treatments like anthracyclines and/or anti-HER2 drugs. If you qualify, you may be offered this heart-protection medicine while your cancer is treated.
Opole, Opole VoivodeshipAges 18 years+ - NCT07304791RecruitingPhase 1
Testing beam-103 safety in healthy volunteers
This trial tests a new drug called BEAM-103 in healthy people to see if it's safe and how the body processes it. It's a single-blind study, meaning you won't know if you get the drug or a placebo.
LondonAges 18–55 - NCT07298343RecruitingPhase 2
Testing ZED1227 for non-responsive celiac disease
This trial tests a new medicine, ZED1227, for people with celiac disease who still have symptoms despite eating gluten-free. The goal is to see if it helps reduce those symptoms.
MainzAges 18–80 - NCT06620770Recruiting
Study on education program for patients on biotherapy
This trial tests whether a therapeutic education program helps people with chronic inflammatory diseases who are on biotherapy injections stick to their treatment and feel better. The program aims to improve compliance and quality of life.
LorientAges 18 years+ - NCT07302386Recruiting
Exercise management in Parkinson's disease
This study tests an exercise program you can do from home using video calls. It aims to improve your walking and balance, and help you manage Parkinson's symptoms.
Maltepe, IstanbulAges 45–80 - NCT07303686RecruitingPhase 4
Reducing Stelara dose in Crohn's and colitis remission
This trial studies whether people with Crohn's disease or ulcerative colitis who are in deep remission can safely reduce their dose of ustekinumab (Stelara) without the disease coming back. It aims to reduce medication burden while keeping patients well.
Montreal, QuebecAges 18 years+ - NCT07305454Recruiting
Teaching exercise habits for Crohn's and colitis
This study tests whether structured education sessions about exercise can help people with Crohn's or colitis be more active. It looks at how this education affects your physical activity levels and overall health.
ToulouseAges 18–100 - NCT07306104Recruiting
Long-term daily brain stimulation with mild electromagnets for Parkinson's
This trial tests whether daily, long-term use of pulsed electromagnetic fields applied to the head can help reduce Parkinson's symptoms. It is for people with mild to moderate Parkinson's who are not on certain blood thinners and have no major health complications like other neurological diseases or active implants.
OdenseAges 18 years+ - NCT07299279Recruiting
Exercise for Brain Health in Parkinson's
This trial studies whether a physical activity program can improve brain health and thinking skills in people with Parkinson's disease who also have mild cognitive impairment. It is designed for those who are not already very active.
Roma, RomeAges 30–80 - NCT07299448Recruiting
Parkinson's and swallowing: what drives difficulty?
This study looks at why some people with Parkinson's have trouble swallowing (dysphagia) and how the brain adapts. It aims to understand the condition better, which could lead to better treatments.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07305116RecruitingPhase 1
CAR T-cell therapy for autoimmune diseases
This trial tests a new immune therapy called CAR T-cells that target two proteins (CD19 and BCMA) to treat autoimmune diseases like lupus, nephrotic syndrome, and others. It is for people whose standard treatments have not worked well enough.
Hangzhou, ZhejiangAges 3 years+ - NCT07300553RecruitingPhase 2
Gut bacteria and energy metabolism in health and IBD
This study looks at how the bacteria living in your gut affect your body's energy use. It includes both healthy volunteers and people with inactive Crohn's disease or ulcerative colitis.
ParisAges 18–50 - NCT07305090Recruiting
Gut GVHD biomarker study for transplant patients
This trial aims to develop a test using multiple biomarkers to predict how well patients will respond to treatment for acute graft-versus-host disease (GVHD) affecting the gut. It focuses on patients who are receiving an allogeneic stem cell transplant.
Bologna, BolognaAges 12 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,408 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.